Artivion | CRY - Actif À Court Terme

Prix De L'Action
35.29
Variation Quotidienne
-1.10 -3.02%
Mensuellement
-8.46%
Annuel
45.53%
Q1 Prévisions
35.04




Actif À Court Terme Changement Date
Abbott USD 26B 1.16B 2025-12
Accuray USD 303.6M 13.86M 2025-09
AngioDynamics USD 161.35M 4.69M 2025-09
Artivion USD 358.08M 20.58M 2025-12
AtriCure USD 322.52M 21.41M 2025-12
Baxter International USD 6.87B 61M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Edwards Lifesciences USD 6.36B 218.3M 2025-09
Inogen USD 203.72M 594K 2025-09
Integra LifeSciences USD 1.16B 15.96M 2025-12
J&J USD 55.62B 1.01B 2025-12
Mesa Laboratories USD 105.63M 8.2M 2025-12
Orthofix International USD 416.85M 22.68M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
ResMed USD 3.82B 193.06M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Surmodics USD 81.3M 948K 2024-09
Tandem Diabetes Care USD 618.14M 1.2M 2025-12
Teleflex USD 1.94B 47.65M 2025-12
Terumo JPY 815.56B 71.48B 2025-12
Trinity Biotech USD 35.52M 2.52M 2025-09